Instructions & Troubleshooting for HybridSPE® DPX® Tips

Importance of the Topic

Phospholipid contamination is a leading cause of ion suppression in liquid chromatography–mass spectrometry (LC/MS) analyses of biological samples. Effective removal of proteins and phospholipids is critical to enhance assay sensitivity, reproducibility, and throughput in pharmaceutical, clinical, and bioanalytical laboratories.

Objectives and Study Overview

This data sheet outlines the HybridSPE DPX sample preparation platform, which combines protein precipitation with a zirconia-based solid-phase extraction in disposable pipette tips. The goal is to achieve rapid and generic cleanup of plasma and serum samples prior to LC/MS or LC/MS/MS analysis.

Methodology and Instrumentation

The workflow consists of:

1. Spiking plasma or serum with internal standard and transferring to a centrifuge tube or deep-well plate.
2. Adding 1% formic acid in acetonitrile at a 1:3 sample-to-solvent ratio to precipitate proteins.
3. Vortexing for 1–3 minutes and centrifuging at 3000 rpm for 2–5 minutes to remove precipitated proteins.
4. Transferring the supernatant to a collection plate and conditioning HybridSPE DPX tips with 1% formic acid in acetonitrile.
5. Aspirating and dispensing the supernatant through the DPX tips three times to retain phospholipids via Lewis acid–base interactions with zirconia.
6. Collecting the eluate for direct LC/MS analysis or optional evaporation and reconstitution to concentrate analytes.

Two tip sizes are available: 30 mg sorbent for 30–100 µL samples and 50 mg sorbent for 100–300 µL samples. Centrifuge, pipetting platforms (e.g., Tecan, Hamilton, INTEGRA), and standard LC/MS or LC/MS/MS systems are used.

Applied Instrumentation

The method is compatible with common laboratory equipment:

• Pipette-based DPX tips (30 mg and 50 mg sorbent).
• High-speed centrifuge for protein removal.
• Multi-channel or automated pipetting platforms (Tecan, Hamilton, INTEGRA).
• LC/MS or LC/MS/MS instruments for final analysis.

Main Results and Discussion

HybridSPE DPX tips remove over 98% of endogenous phospholipids and gross protein interferences without the need for complex hardware. The eluent, consisting of 75% acetonitrile with formic acid, is ready for direct injection. Troubleshooting guidance addresses issues such as low analyte recovery—recommendations include alternative precipitation agents (e.g., ammonium formate in methanol or citric acid in acetonitrile) and optimization of aspirate/dispense cycles.

Benefits and Practical Applications

The HybridSPE DPX approach offers:

• Rapid sample cleanup in under 10 minutes for up to 300 µL plasma.
• Elimination of vacuum or positive-pressure manifolds.
• Flexible use on manual or automated platforms.
• Compatibility with downstream LC/MS workflows without evaporation or reconstitution steps unless concentration is desired.

Future Trends and Applications

Emerging developments include integration with fully automated sample-prep robots, adaptation to additional biological matrices, and exploration of novel sorbent chemistries to target a broader range of endogenous interferences. High-throughput screening and clinical diagnostic applications may further benefit from streamlined DPX workflows.

Conclusion

The HybridSPE DPX platform provides a robust, generic, and efficient strategy for removing phospholipids and proteins from plasma and serum. Its simplicity, speed, and compatibility with standard LC/MS systems make it a valuable tool for improving assay sensitivity and reliability in bioanalytical laboratories.